L20.83 Infantile (acute) (chronic) eczema

Name of the Condition

• Infantile (Acute) (Chronic) Eczema (ICD-10 Code: L20.83)

Summary

Infantile (acute) (chronic) eczema is a form of atopic dermatitis that typically presents in infants and young children. It is characterized by dry, itchy, and inflamed skin, with symptoms that may be acute (sudden onset) or chronic (persistent). The condition often follows a relapsing-remitting course and is associated with a personal or family history of atopic diseases. It primarily affects the skin barrier, leading to increased susceptibility to irritants and allergens.

Causes

The exact cause is multifactorial, involving genetic predisposition, immune system dysregulation, and environmental triggers. Skin barrier dysfunction due to filaggrin gene mutations is a key factor, allowing irritants and allergens to penetrate more easily and trigger inflammation. Other potential contributors include microbial colonization (e.g., Staphylococcus aureus) and immune system abnormalities.

Risk Factors

• Family history of atopic diseases (e.g., asthma, allergic rhinitis).
• Personal history of other atopic conditions.
• Exposure to environmental irritants (e.g., soaps, detergents, wool).
• Low humidity or extreme temperatures.
• Stress or hormonal changes.

Symptoms

• Intense itching (pruritus) that may worsen at night.
• Dry, scaly, or cracked skin.
• Red to brownish-gray patches, often on the face, scalp, or extensor surfaces (e.g., cheeks, forehead, outer arms/legs).
• Possible oozing or crusting in acute flare-ups.
• Thickened skin (lichenification) from chronic scratching.

Diagnosis

Diagnosis is primarily clinical, based on patient history and physical examination. Healthcare providers may assess for signs of atopic dermatitis, including distribution of lesions, chronicity, and associated symptoms. In some cases, patch testing or skin biopsies may be considered to rule out other conditions or identify specific triggers.

Treatment Options

• Topical corticosteroids or calcineurin inhibitors to reduce inflammation.
• Emollients to maintain skin hydration and barrier function.
• Antihistamines for itching relief.
• Moisturizing baths and gentle skin care routines.
• Avoidance of known irritants or allergens.

Prognosis and Follow-Up

Infantile eczema often improves with age, though some individuals may experience persistent symptoms into adulthood. Regular follow-up is important to monitor for flare-ups, adjust treatment, and address any complications. Long-term management focuses on maintaining skin barrier integrity and minimizing triggers.

Complications

• Secondary bacterial or viral infections (e.g., impetigo, herpes simplex).
• Sleep disturbances due to itching.
• Skin thickening or scarring from chronic scratching.
• Psychological impact, such as anxiety or social withdrawal.

Lifestyle & Prevention

• Use gentle, fragrance-free soaps and moisturizers.
• Avoid known irritants (e.g., wool, harsh detergents).
• Maintain consistent skin hydration with emollients.
• Dress in breathable, soft fabrics (e.g., cotton).
• Keep nails short to reduce scratching damage.

When to Seek Professional Help

• Symptoms worsen or do not improve with home care.
• Signs of infection (e.g., pus, increased redness, fever).
• Severe itching interfering with sleep or daily activities.
• New or unexplained skin changes.

Tips for Medical Coders

• Code L20.83 is specific to infantile (acute) (chronic) eczema and should be used when documentation supports this diagnosis.
• Ensure documentation includes details about the onset (acute/chronic) and age of onset (infantile) to justify the code.
• Avoid using this code for other forms of eczema or atopic dermatitis without clear clinical correlation.
• Verify that the code aligns with the patient's age and clinical presentation to ensure accurate coding.